Predict your next investment

Corporation
HEALTHCARE | Biotechnology
amicusrx.com

See what CB Insights has to offer

Founded Year

2002

Stage

PIPE | IPO

Total Raised

$146M

Market Cap

3.01B

Stock Price

10.80

About Amicus Therapeutics

Amicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.

Amicus Therapeutics Headquarter Location

1 Cedar Brook Drive

Cranbury, New Jersey, 08512,

United States

609-662-2000

Latest Amicus Therapeutics News

Amicus Therapeutics To Present At The 4th Annual Evercore ISI HealthCONx Virtual Conference

Nov 24, 2021

Amicus Therapeutics To Present At The 4th Annual Evercore ISI HealthCONx Virtual Conference PHILADELPHIA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the 4 th Annual Evercore ISI HealthCONx Virtual Conference on... Author: PHILADELPHIA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the 4 th Annual Evercore ISI HealthCONx Virtual Conference on Wednesday, December 1, 2021 at 8:50 a.m. E.T. A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations . About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company's website at www.amicusrx.com , and follow us on Twitter and LinkedIn . CONTACT: Media:Diana MooreHead of Global Corporate Affairs & Communications dmoore@amicusrx.com (609) 662-5079 FOLD-G

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Amicus Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Amicus Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Amicus Therapeutics Patents

Amicus Therapeutics has filed 143 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Autosomal recessive disorders
  • Proteins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/10/2019

8/24/2021

Autosomal recessive disorders, Rare diseases, Molecular biology, Protein domains, Transcription factors

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/10/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/24/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Autosomal recessive disorders, Rare diseases, Molecular biology, Protein domains, Transcription factors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amicus Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Amicus Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.